Astex Pharmaceuticals to Present at September Investor Conferences

| Source: Astex Pharmaceuticals, Inc.

DUBLIN, Calif., Aug. 30, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced that members of its senior management team will present at the following investor conferences in September:

Stifel Nicolaus Healthcare Conference
Thursday, September 6 at 10:55 am ET
Boston, MA
BioCentury and Thomson Reuters' NewsMakers in the Biotech Industry
Friday, September 7 at 10:00 am ET
New York, NY
Rodman & Renshaw Global Investment Conference
Monday, September 10 at 11:40 am ET
New York, NY

Webcast information and presentation materials will be available in the Investor Events section of the Company's website, Both will be archived for 30 days.

About Astex Pharmaceuticals

Astex Pharmaceuticals is dedicated to the discovery and development of novel small molecule therapeutics with a focus on oncology. The Company is developing a proprietary pipeline of novel therapies and is creating de-risked products for partnership with leading pharmaceutical companies. Astex Pharmaceuticals developed Dacogen® (decitabine) for Injection and receives significant royalties on global sales.

For more information about Astex Pharmaceuticals, Inc., please visit

The Astex Pharmaceuticals, Inc. logo is available at

Timothy L. Enns
Astex Pharmaceuticals, Inc.
Senior Vice President
Corporate Communications & Marketing
Tel:  +1 (925) 560-2810

Susanna Chau
Astex Pharmaceuticals, Inc.
Investor Relations
Tel:  +1 (925) 560-2845

Alan Roemer
The Trout Group
Managing Director
Tel:  +1 (646) 378-2945

Kari Watson
MacDougall Biomedical Communications
Senior Vice President
Tel: +1 (781) 235-3060